메뉴 건너뛰기




Volumn 9, Issue 1, 2015, Pages 282-294

Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo

Author keywords

Brk; Combined; ErbB2; PLA; Proximity ligation assay; RNA interference

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 6; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; ERBB3 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; PTK6 PROTEIN, HUMAN; SOMATOMEDIN RECEPTOR; TUMOR PROTEIN;

EID: 84920367952     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.08.012     Document Type: Article
Times cited : (13)

References (51)
  • 1
    • 0042358985 scopus 로고    scopus 로고
    • Cell culture: biology's new dimension
    • Abbott A. Cell culture: biology's new dimension. Nature 2003, 424:870-872.
    • (2003) Nature , vol.424 , pp. 870-872
    • Abbott, A.1
  • 2
    • 84879267570 scopus 로고    scopus 로고
    • HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain
    • Ai M., Qiu S., Lu Y., Fan Z. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain. Cell. Signal. 2013, 25:1754-1761.
    • (2013) Cell. Signal. , vol.25 , pp. 1754-1761
    • Ai, M.1    Qiu, S.2    Lu, Y.3    Fan, Z.4
  • 5
    • 0030827253 scopus 로고    scopus 로고
    • BRK tyrosine kinase expression in a high proportion of human breast carcinomas
    • Barker K.T., Jackson L.E., Crompton M.R. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997, 15:799-805.
    • (1997) Oncogene , vol.15 , pp. 799-805
    • Barker, K.T.1    Jackson, L.E.2    Crompton, M.R.3
  • 6
    • 0020456385 scopus 로고
    • How does the extracellular matrix direct gene expression?
    • Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression?. J.Theor. Biol. 1982, 99:31-68.
    • (1982) J.Theor. Biol. , vol.99 , pp. 31-68
    • Bissell, M.J.1    Hall, H.G.2    Parry, G.3
  • 7
    • 78049516402 scopus 로고    scopus 로고
    • Deregulation of the cell cycle by breast tumor kinase (Brk)
    • Chan E., Nimnual A.S. Deregulation of the cell cycle by breast tumor kinase (Brk). Int. J. Cancer 2010, 127:2723-2731.
    • (2010) Int. J. Cancer , vol.127 , pp. 2723-2731
    • Chan, E.1    Nimnual, A.S.2
  • 8
    • 10044284340 scopus 로고    scopus 로고
    • Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin
    • Chen H.Y., Shen C.H., Tsai Y.T., Lin F.C., Huang Y.P., Chen R.H. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol. 2004, 24:10558-10572.
    • (2004) Mol. Cell. Biol. , vol.24 , pp. 10558-10572
    • Chen, H.Y.1    Shen, C.H.2    Tsai, Y.T.3    Lin, F.C.4    Huang, Y.P.5    Chen, R.H.6
  • 9
    • 0037429779 scopus 로고    scopus 로고
    • The deaf and the dumb: the biology of ErbB-2 and ErbB-3
    • Citri A., Skaria K.B., Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 2003, 284:54-65.
    • (2003) Exp. Cell Res. , vol.284 , pp. 54-65
    • Citri, A.1    Skaria, K.B.2    Yarden, Y.3
  • 10
    • 0038713797 scopus 로고    scopus 로고
    • Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells
    • Derry J.J., Prins G.S., Ray V., Tyner A.L. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 2003, 22:4212-4220.
    • (2003) Oncogene , vol.22 , pp. 4212-4220
    • Derry, J.J.1    Prins, G.S.2    Ray, V.3    Tyner, A.L.4
  • 11
    • 83455236148 scopus 로고    scopus 로고
    • Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues
    • Drewitz M., Helbling M., Fried N., Bieri M., Moritz W., Lichtenberg J., Kelm J.M. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol. J. 2011, 6:1488-1496.
    • (2011) Biotechnol. J. , vol.6 , pp. 1488-1496
    • Drewitz, M.1    Helbling, M.2    Fried, N.3    Bieri, M.4    Moritz, W.5    Lichtenberg, J.6    Kelm, J.M.7
  • 12
    • 84901853867 scopus 로고    scopus 로고
    • Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance
    • Easwaran H., Tsai H.C., Baylin S.B. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 2014, 54:716-727.
    • (2014) Mol. Cell , vol.54 , pp. 716-727
    • Easwaran, H.1    Tsai, H.C.2    Baylin, S.B.3
  • 13
    • 35148859334 scopus 로고    scopus 로고
    • Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate
    • Eddy S.F., Kane S.E., Sonenshein G.E. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 2007, 67:9018-9023.
    • (2007) Cancer Res. , vol.67 , pp. 9018-9023
    • Eddy, S.F.1    Kane, S.E.2    Sonenshein, G.E.3
  • 15
    • 84883189052 scopus 로고    scopus 로고
    • Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells
    • Fan G., Lin G., Lucito R., Tonks N.K. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells. J.Biol. Chem. 2013, 288:24923-24934.
    • (2013) J.Biol. Chem. , vol.288 , pp. 24923-24934
    • Fan, G.1    Lin, G.2    Lucito, R.3    Tonks, N.K.4
  • 17
    • 84886028975 scopus 로고    scopus 로고
    • High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells
    • Hongisto V., Jernstrom S., Fey V., Mpindi J.P., Kleivi Sahlberg K., Kallioniemi O., Perala M. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PloS One 2013, 8:e77232.
    • (2013) PloS One , vol.8 , pp. e77232
    • Hongisto, V.1    Jernstrom, S.2    Fey, V.3    Mpindi, J.P.4    Kleivi Sahlberg, K.5    Kallioniemi, O.6    Perala, M.7
  • 18
    • 33745208666 scopus 로고    scopus 로고
    • Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth invitro and invivo
    • Hu X., Su F., Qin L., Jia W., Gong C., Yu F., Guo J., Song E. Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth invitro and invivo. Biochem. Biophys. Res. Commun. 2006, 346:778-785.
    • (2006) Biochem. Biophys. Res. Commun. , vol.346 , pp. 778-785
    • Hu, X.1    Su, F.2    Qin, L.3    Jia, W.4    Gong, C.5    Yu, F.6    Guo, J.7    Song, E.8
  • 21
    • 0034676337 scopus 로고    scopus 로고
    • Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation
    • Kamalati T., Jolin H.E., Fry M.J., Crompton M.R. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 2000, 19:5471-5476.
    • (2000) Oncogene , vol.19 , pp. 5471-5476
    • Kamalati, T.1    Jolin, H.E.2    Fry, M.J.3    Crompton, M.R.4
  • 23
    • 41949125812 scopus 로고    scopus 로고
    • Lapatinib: a sword with two edges
    • Kopper L. Lapatinib: a sword with two edges. Pathol. Oncol. Res. 2008, 14:1-8.
    • (2008) Pathol. Oncol. Res. , vol.14 , pp. 1-8
    • Kopper, L.1
  • 24
    • 35348905119 scopus 로고    scopus 로고
    • RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth
    • Kunigal S., Lakka S.S., Gondi C.S., Estes N., Rao J.S. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int. J. Cancer 2007, 121:2307-2316.
    • (2007) Int. J. Cancer , vol.121 , pp. 2307-2316
    • Kunigal, S.1    Lakka, S.S.2    Gondi, C.S.3    Estes, N.4    Rao, J.S.5
  • 26
    • 77956594900 scopus 로고    scopus 로고
    • RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells
    • Li C., Cao S., Liu Z., Ye X., Chen L., Meng S. RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells. Int. J. Cancer 2010, 127:1507-1516.
    • (2010) Int. J. Cancer , vol.127 , pp. 1507-1516
    • Li, C.1    Cao, S.2    Liu, Z.3    Ye, X.4    Chen, L.5    Meng, S.6
  • 27
    • 34347218991 scopus 로고    scopus 로고
    • Invitro scratch assay: a convenient and inexpensive method for analysis of cell migration invitro
    • Liang C.C., Park A.Y., Guan J.L. Invitro scratch assay: a convenient and inexpensive method for analysis of cell migration invitro. Nat. Protoc. 2007, 2:329-333.
    • (2007) Nat. Protoc. , vol.2 , pp. 329-333
    • Liang, C.C.1    Park, A.Y.2    Guan, J.L.3
  • 28
    • 33746897689 scopus 로고    scopus 로고
    • Identification of STAT3 as a specific substrate of breast tumor kinase
    • Liu L., Gao Y., Qiu H., Miller W.T., Poli V., Reich N.C. Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene 2006, 25:4904-4912.
    • (2006) Oncogene , vol.25 , pp. 4904-4912
    • Liu, L.1    Gao, Y.2    Qiu, H.3    Miller, W.T.4    Poli, V.5    Reich, N.C.6
  • 30
    • 79954459766 scopus 로고    scopus 로고
    • Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer
    • Ludyga N., Anastasov N., Gonzalez-Vasconcellos I., Ram M., Hofler H., Aubele M. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer. Mol. Biosystems 2011, 7:1603-1612.
    • (2011) Mol. Biosystems , vol.7 , pp. 1603-1612
    • Ludyga, N.1    Anastasov, N.2    Gonzalez-Vasconcellos, I.3    Ram, M.4    Hofler, H.5    Aubele, M.6
  • 32
    • 0030763257 scopus 로고    scopus 로고
    • Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk
    • Mitchell P.J., Barker K.T., Shipley J., Crompton M.R. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk. Oncogene 1997, 15:1497-1502.
    • (1997) Oncogene , vol.15 , pp. 1497-1502
    • Mitchell, P.J.1    Barker, K.T.2    Shipley, J.3    Crompton, M.R.4
  • 33
    • 34547854801 scopus 로고    scopus 로고
    • The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
    • Moasser M.M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007, 26:6469-6487.
    • (2007) Oncogene , vol.26 , pp. 6469-6487
    • Moasser, M.M.1
  • 34
    • 34248327833 scopus 로고    scopus 로고
    • Counting colonies of clonogenic assays by using densitometric software
    • Niyazi M., Niyazi I., Belka C. Counting colonies of clonogenic assays by using densitometric software. Radiat. Oncol. 2007, 2:4.
    • (2007) Radiat. Oncol. , vol.2 , pp. 4
    • Niyazi, M.1    Niyazi, I.2    Belka, C.3
  • 35
    • 34249339776 scopus 로고    scopus 로고
    • Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
    • Ostrander J.H., Daniel A.R., Lofgren K., Kleer C.G., Lange C.A. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 2007, 67:4199-4209.
    • (2007) Cancer Res. , vol.67 , pp. 4199-4209
    • Ostrander, J.H.1    Daniel, A.R.2    Lofgren, K.3    Kleer, C.G.4    Lange, C.A.5
  • 36
    • 84890150360 scopus 로고    scopus 로고
    • Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
    • Peng M., Ball-Kell S.M., Franks R.R., Xie H., Tyner A.L. Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models. Oncogene 2013, 2:e81.
    • (2013) Oncogene , vol.2 , pp. e81
    • Peng, M.1    Ball-Kell, S.M.2    Franks, R.R.3    Xie, H.4    Tyner, A.L.5
  • 37
    • 59649109230 scopus 로고    scopus 로고
    • Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab
    • Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009, 28:461-468.
    • (2009) Oncogene , vol.28 , pp. 461-468
    • Pickl, M.1    Ries, C.H.2
  • 38
    • 24644462342 scopus 로고    scopus 로고
    • Interaction between Brk kinase and insulin receptor substrate-4
    • Qiu H., Zappacosta F., Su W., Annan R.S., Miller W.T. Interaction between Brk kinase and insulin receptor substrate-4. Oncogene 2005, 24:5656-5664.
    • (2005) Oncogene , vol.24 , pp. 5656-5664
    • Qiu, H.1    Zappacosta, F.2    Su, W.3    Annan, R.S.4    Miller, W.T.5
  • 40
    • 0038499519 scopus 로고    scopus 로고
    • Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases
    • Serfas M.S., Tyner A.L. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol. Res. 2003, 13:409-419.
    • (2003) Oncol. Res. , vol.13 , pp. 409-419
    • Serfas, M.S.1    Tyner, A.L.2
  • 41
    • 36249003805 scopus 로고    scopus 로고
    • The HER family and cancer: emerging molecular mechanisms and therapeutic targets
    • Sergina N.V., Moasser M.M. The HER family and cancer: emerging molecular mechanisms and therapeutic targets. Trends Mol. Med. 2007, 13:527-534.
    • (2007) Trends Mol. Med. , vol.13 , pp. 527-534
    • Sergina, N.V.1    Moasser, M.M.2
  • 43
    • 0035259989 scopus 로고    scopus 로고
    • Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials
    • Sparano J.A. Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials. Semin. Oncol. 2001, 28:20-27.
    • (2001) Semin. Oncol. , vol.28 , pp. 20-27
    • Sparano, J.A.1
  • 45
    • 33744725239 scopus 로고    scopus 로고
    • SiRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells
    • Subramanian R., Gondi C.S., Lakka S.S., Jutla A., Rao J.S. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int. J. Oncol. 2006, 28:831-839.
    • (2006) Int. J. Oncol. , vol.28 , pp. 831-839
    • Subramanian, R.1    Gondi, C.S.2    Lakka, S.S.3    Jutla, A.4    Rao, J.S.5
  • 46
    • 0014984766 scopus 로고
    • Growth of multicell spheroids in tissue culture as a model of nodular carcinomas
    • Sutherland R.M., McCredie J.A., Inch W.R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J.Natl. Cancer Inst. 1971, 46:113-120.
    • (1971) J.Natl. Cancer Inst. , vol.46 , pp. 113-120
    • Sutherland, R.M.1    McCredie, J.A.2    Inch, W.R.3
  • 47
    • 0035073872 scopus 로고    scopus 로고
    • Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells
    • Wartenberg M., Donmez F., Ling F.C., Acker H., Hescheler J., Sauer H. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J. 2001, 15:995-1005.
    • (2001) FASEB J. , vol.15 , pp. 995-1005
    • Wartenberg, M.1    Donmez, F.2    Ling, F.C.3    Acker, H.4    Hescheler, J.5    Sauer, H.6
  • 48
    • 40349103609 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6
    • Weaver A.M., Silva C.M. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Breast Cancer Res. 2007, 9:R79.
    • (2007) Breast Cancer Res. , vol.9 , pp. R79
    • Weaver, A.M.1    Silva, C.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.